Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer (Q27851410)

PubMed

PubMed publication ID

17625570

13 November 2016

title

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer (English)

1 reference

PubMed

PubMed publication ID

13 November 2016

1 reference

14

Hiroyuki Aburatani

0 references

author name string

Manabu Soda

1

0 references

Young Lim Choi

2

0 references

Munehiro Enomoto

3

0 references

Shuji Takada

4

0 references

Yoshihiro Yamashita

5

0 references

Shunpei Ishikawa

6

0 references

Shin-ichiro Fujiwara

7

0 references

Hideki Watanabe

8

0 references

Kentaro Kurashina

9

0 references

Hisashi Hatanaka

10

0 references

Masashi Bando

11

0 references

Shoji Ohno

12

0 references

Yuichi Ishikawa

13

0 references

Toshiro Niki

15

0 references

Yasunori Sohara

16

0 references

Yukihiko Sugiyama

17

0 references

Hiroyuki Mano

18

0 references

publication date

2 August 2007

0 references

language of work or name

0 references

0 references

448

0 references

issue

7153

0 references

page(s)

561-6

0 references

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

An alternative transcript derived from the trio locus encodes a guanosine nucleotide exchange factor with mouse cell-transforming potential

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Transforming activity of purinergic receptor P2Y, G-protein coupled, 2 revealed by retroviral expression screening

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Identification of a constitutively active mutant of JAK3 by retroviral expression screening

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Transforming activity of the lymphotoxin-beta receptor revealed by expression screening

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Human EML4, a novel member of the EMAP family, is essential for microtubule formation

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

The Human EMAP-like Protein-70 (ELP70) Is a Microtubule Destabilizer That Localizes to the Mitotic Apparatus

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

The WD repeat: a common architecture for diverse functions

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Anaplastic lymphoma kinase proteins in growth control and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Design and synthesis of 5-aryl-pyridone-carboxamides as inhibitors of anaplastic lymphoma kinase

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

JAK2 is essential for activation of c-fos and c-myc promoters and cell proliferation through the human granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Translocations involving anaplastic lymphoma kinase (ALK).

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021

Sak serine-threonine kinase acts as an effector of Tec tyrosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05945

7 January 2021